L26/P-073 Microfluidic-Integrated Free-space Angular-Chirp-Enhanced Delay (FACED) Imaging: A Novel Platform for Isolating Fertilization-Competent Human Spermatozoa for Assisted Reproduction
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E.T.Y. Leung und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can a microfluidic-integrated platform leveraging intrinsic physiological properties selectively isolate and facilitate the functional examination of fertilization-competent human spermatozoa? Summary answer Our results demonstrated the successful application of a microfluidic-integrated free-space angular-chirp-enhanced delay (FACED) imaging platform to isolate and examine spermatozoa with zona pellucida (ZP)-binding ability. What is known already Conventional semen analysis is a fundamental tool for evaluating male infertility, but its ability to predict assisted reproduction treatment (ART) outcome is limited due to its labor-intensive, subjective, and operator-dependent nature. Human zona pellucida (ZP)–binding capacity is a sperm quality metric that correlates more closely with IVF fertilization rates and pregnancy outcomes. Microfluidic technologies offer a promising approach for exploiting the intrinsic properties and motility of spermatozoa within a controlled microenvironment. When integrated with advanced imaging systems, a well-designed microfluidic chip enable detailed investigation of sperm intracellular structures and their clinical relevance for sperm analysis and selection. Study design, size, duration Human spermatozoa and oocytes were obtained from consenting donors enrolled in our assisted reproduction program. ZP-bound, acrosome-intact spermatozoa were isolated using a sperm-oocyte coincubation assay, and unbound spermatozoa were collected according to clinical inclusion criteria. Sperm DNA integrity and chromatin organization were assessed using TUNEL and chromomycin A3 staining. A custom-designed microfluidic device was used to isolate spermatozoa with ZP-binding ability for advanced image analysis. Participants/materials, setting, methods ZP-bound and unbound spermatozoa were analyzed using optimized protocols to assess DNA fragmentation and protamine deficiency. A passive microfluidic device was developed to automatically isolate ZP-bound spermatozoa by guiding oocytes with attached sperm through three microchannels of decreasing widths (150, 130, and 100 μm), utilizing physical barriers and a constant flow rate to facilitate separation. Images of freely swimming, live ZP-bound spermatozoa were acquired with a FACED imaging platform for downstream morphological analysis. Main results and the role of chance ZP-bound spermatozoa exhibited significantly lower levels of DNA fragmentation and protamine deficiency, as indicated by TUNEL and CMA3 staining, compared to their unbound counterparts. The custom-designed microfluidic device effectively separated ZP-bound spermatozoa from oocytes within minutes. Under the influence of capillary action and a constant flow rate (20 mL/min), oocytes (n = 9; 10 oocytes per group) with attached spermatozoa were gently guided through the microchannels, mimicking the effects of vigorous pipetting. Detached, motile spermatozoa successfully migrated from the main chamber toward the outlet, driven by boundary-following behavior and the ability to navigate corners. Our results indicated an average recovery yield of 80% for freely, swimming ZP-bound spermatozoa, with improved DNA fragmentation rates compared to the raw sample. Beyond separation, the FACED platform captured high-resolution, label-free images of freely swimming spermatozoa within microchannels, overcoming the limitations of conventional imaging systems lacking high-speed imaging capabilities. Using quantitative phase imaging (QPI), the system enabled detailed visualization and analysis of sperm head morphology. Heat maps generated from 40,000 spermatozoa revealed nine key morphological and phase features: area, perimeter, circularity, major axis, minor axis, aspect ratio, dry mass, phase mean, and phase variation. Limitations, reasons for caution Our platform is specifically designed to facilitate the transportation of immotile oocytes through a combination of laminar flow and capillary action. Further investigation is necessary to optimize the channel geometry and flow distribution generated by syringe pumps at various flow rates, ensuring consistent efficiency and high throughput. Wider implications of the findings Our novel microfluidic device isolates high-quality human spermatozoa by leveraging their intrinsic properties and functional competency. Coupled with label-free QPI analysis of live, label-free spermatozoa, it provides detailed metrics on key morphological and intracellular features, offering a more comprehensive sperm assessment that can enhance clinical decision-making in ART. Trial registration number No
Zitieren
APA
Leung, E., Lo, M., Xie, Y., Jiang, Z., Tsia, K., & Chiu, P. (2026). L26/P-073 Microfluidic-Integrated Free-space Angular-Chirp-Enhanced Delay (FACED) Imaging: A Novel Platform for Isolating Fertilization-Competent Human Spermatozoa for Assisted Reproduction. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.409
Vancouver
Leung E, Lo M, Xie Y, Jiang Z, Tsia K, Chiu P. L26/P-073 Microfluidic-Integrated Free-space Angular-Chirp-Enhanced Delay (FACED) Imaging: A Novel Platform for Isolating Fertilization-Competent Human Spermatozoa for Assisted Reproduction. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.409
BibTeX
@article{Leung2026,
author = {Leung, E.T.Y. and Lo, M.C.K. and Xie, Y. and Jiang, Z. and Tsia, K.K.M. and Chiu, P.C.N.},
title = {L26/P-073 Microfluidic-Integrated Free-space Angular-Chirp-Enhanced Delay (FACED) Imaging: A Novel Platform for Isolating Fertilization-Competent Human Spermatozoa for Assisted Reproduction},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.409}
}
EUVIMED